Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota

Clinical and Experimental Immunology

Volumn 179, Issue 3, 2015, Pages 363-377

  Peterson, C T ^a   Sharma, V ^b   Elmen L ^b   Peterson, S N ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Bacterial; Host pathogen interactions; Inflammation; Mucosa

Indexed keywords

PROBIOTIC AGENT;

AGED; ANTIBIOTIC THERAPY; DYSBIOSIS; FECAL MICROBIOME TRANSPLANTATION; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIOME; PRIORITY JOURNAL; REVIEW; TRANSPLANTATION; ANIMAL; BACTERIUM; BIOLOGICAL THERAPY; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MICROFLORA; MUCOSAL IMMUNITY;

ANIMALS; BACTERIA; BIOLOGICAL THERAPY; DYSBIOSIS; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY, MUCOSAL; IMMUNOMODULATION; INTESTINES; MICROBIOTA; PROBIOTICS;

EID: 84922805709     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12474     Document Type: Review

References (146)

1. Eckburg PB, Bik EM, Bernstein CN etal. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-1638. doi: 10.1126/science.1110591.
2. Sonnenburg JL, Chen CT, Gordon JI. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLOS Biol 2006; 4:e413. doi: 10.1371/journal.pbio.0040413.
3. Samuel BS, Gordon JI. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci USA 2006; 103:10011-10016. doi: 10.1073/pnas.0602187103.
4. Chassard C, Bernalier-Donadille A. H2 and acetate transfers during xylan fermentation between a butyrate-producing xylanolytic species and hydrogenotrophic microorganisms from the human gut. FEMS Microbiol Lett 2006; 254:116-122. doi: 10.1111/j.1574-6968.2005.00016.x.
5. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307:1915-1920. doi: 10.1126/science.1104816.
6. Mahowald MA, Rey FE, Seedorf H etal. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA 2009; 106:5859-5864. doi: 10.1073/pnas.0901529106.
7. Fischbach MA, Sonnenburg JL. Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe 2011; 10:336-347. doi: 10.1016/j.chom.2011.10.002.
8. Qin J, Li R, Raes J etal. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65. doi: 10.1038/nature08821.
9. Wen L, Ley RE, Volchkov PY etal. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455:1109-1113. doi: 10.1038/nature07336.
10. Benson AK, Kelly SA, Legge R etal. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci USA 2010; 107:18933-18938. doi: 10.1073/pnas.1007028107.
11. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489:220-230. doi: 10.1038/nature11550.
12. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1:6ra14. doi: 10.1126/scitranslmed.3000322.
13. Turnbaugh PJ, Hamady M, Yatsunenko T etal. A core gut microbiome in obese and lean twins. Nature 2009; 457:480-484. doi: 10.1038/nature07540.
14. Yatsunenko T, Rey FE, Manary MJ etal. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-227. doi: 10.1038/nature11053.
15. Fallani M, Amarri S, Uusijarvi A etal. Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology 2011; 157:1385-1392. doi: 10.1099/mic.0.042143-0.
16. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011; 108 (Suppl. 1):4554-4561. doi: 1073/pnas.1000087107.
17. Mills ME. The CNS and collaborative practice. Clin Nurse Spec 1990; 4:194-195.
18. Claesson MJ, Jeffery IB, Conde S etal. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012; 488:178-184. doi: 10.1038/nature11319.
19. Toward R, Montandon S, Walton G, Gibson GR. Effect of prebiotics on the human gut microbiota of elderly persons. Gut Microbes 2012; 3:57-60. doi: 10.4161/gmic.19411.
20. Jirillo E, Jirillo F, Magrone T. Healthy effects exerted by prebiotics, probiotics, and symbiotics with special reference to their impact on the immune system. Int J Vitam Nutr Res 2012; 82:200-208. doi: 10.1024/0300-9831/a000112.
21. Mueller S, Saunier K, Hanisch C etal. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006; 72:1027-1033. doi: 10.1128/AEM.72.2.1027-1033.2006.
22. Kinross J, Nicholson JK. Gut microbiota: dietary and social modulation of gut microbiota in the elderly. Nat Rev Gastroenterol Hepatol 2012; 9:563-564. doi: 10.1038/nrgastro.2012.169.
23. Claesson MJ, Cusack S, O'Sullivan O etal. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2011; 108 (Suppl. 1):4586-4591. doi: 10.1073/pnas.1000097107.
24. Stout MJ, Conlon B, Landeau M etal. Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol 2013; 208:226.e1-2267. doi: 10.1016/j.ajog.2013.01.018.
25. Jimenez E, Marin ML, Martin R etal. Is meconium from healthy newborns actually sterile? Res Microbiol 2008; 159:187-193. doi: 10.1016/j.resmic.2007.12.007.
26. Zaura E, Nicu EA, Krom BP, Keijser BJ. Acquiring and maintaining a normal oral microbiome: current perspective. Front Cell Infect Microbiol 2014; 4:851-858. doi: 10.3389/fcimb.2014.00085.
27. Gueimonde M, Sakata S, Kalliomaki M, Isolauri E, Benno Y, Salminen S. Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J Pediatr Gastroenterol Nutr 2006; 42:166-170. doi: 10.1097/01.mpg.0000189346.25172.fd.
28. Vaishampayan PA, Kuehl JV, Froula JL, Morgan JL, Ochman H, Francino MP. Comparative metagenomics and population dynamics of the gut microbiota in mother and infant. Genome Biol Evol 2010; 2:53-66. doi: 10.1093/gbe/evp057.
29. Penders J, Thijs C, Vink C etal. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118:511-521. doi: 10.1542/peds.2005-2824.
30. Dominguez-Bello MG, Costello EK, Contreras M etal. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107:11971-11975. doi: 10.1073/pnas.1002601107.
31. Nelun Barfod M, Magnusson K, Lexner MO, Blomqvist S, Dahlen G, Twetman S. Oral microflora in infants delivered vaginally and by caesarean section. Int J Paediatr Dent 2011; 21:401-406. doi: 10.1111/j.1365-263X.2011.01136.x.
32. Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, Retetangos C. Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev 2010; 86 (Suppl. 1):13-15. doi: 10.1016/j.earlhumdev.2010.01.004.
33. Lif Holgerson P, Harnevik L, Hernell O, Tanner AC, Johansson I. Mode of birth delivery affects oral microbiota in infants. J Dent Res 2011; 90:1183-1188. doi: 10.1177/0022034511418973.
34. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLOS Biol 2007; 5:e177. doi: 10.1371/journal.pbio.0050177.
35. Morowitz MJ, Denef VJ, Costello EK etal. Strain-resolved community genomic analysis of gut microbial colonization in a premature infant. Proc Natl Acad Sci USA 2011; 108:1128-1133. doi: 10.1073/pnas.1010992108.
36. Koenig JE, Spor A, Scalfone N etal. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011; 108 (Suppl. 1):4578-4585. doi: 10.1073/pnas.1000081107.
37. Faust K, Sathirapongsasuti JF, Izard J etal. Microbial co-occurrence relationships in the human microbiome. PLOS Comput Biol 2012; 8:e1002606. doi: 10.1371/journal.pcbi.1002606.
38. Faust K, Raes J. Microbial interactions: from networks to models. Nat Rev Microbiol 2012; 10:538-550. doi: 10.1038/nrmicro2832.
39. Backhed F, Ding H, Wang T etal. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101:15718-15723.
40. Relman DA. The human microbiome: ecosystem resilience and health. Nutr Rev 2012; 70 (Suppl. 1):S2-9. doi: 10.1111/j.1753-4887.2012.00489.x.
41. Larsson E, Tremaroli V, Lee YS etal. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut 2012; 61:1124-1131. doi: 10.1136/gutjnl-2011-301104.
42. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1:135-145. doi: 10.1038/35100529.
43. Sanderson IR, Walker WA. TLRs in the Gut I. The role of TLRs/NODs in intestinal development and homeostasis. Am J Physiol Gastrointest Liver Physiol 2007; 292:G6-10. doi: 10.1152/ajpgi.00275.2006.
44. Sansonetti PJ, Medzhitov R. Learning tolerance while fighting ignorance. Cell 2009; 138:416-420. doi: 10.1016/j.cell.2009.07.024.
45. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10:159-169. doi: 10.1038/nri2710.
46. Kobayashi KS, Chamaillard M, Ogura Y etal. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307:731-734. doi: 10.1126/science.1104911.
47. Ganal SC, Sanos SL, Kallfass C etal. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012; 37:171-186. doi: 10.1016/j.immuni.2012.05.020.
48. Izcue A, Coombes JL, Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 2006; 212:256-271. doi: 10.1111/j.0105-2896.2006.00423.x.
49. Cebula A, Seweryn M, Rempala GA etal. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 2013; 497:258-262. doi: 10.1038/nature12079.
50. Collier-Hyams LS, Sloane V, Batten BC, Neish AS. Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J Immunol 2005; 175:4194-4198.
51. Kelly D, Campbell JI, King TP etal. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004; 5:104-112. doi: 10.1038/ni1018.
52. Tien MT, Girardin SE, Regnault B etal. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 2006; 176:1228-1237.
53. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620-625. doi: 10.1038/nature07008.
54. Atarashi K, Tanoue T, Shima T etal. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337-341. doi: 10.1126/science.1198469.
55. Atarashi K, Nishimura J, Shima T etal. ATP drives lamina propria T(H)17 cell differentiation. Nature 2008; 455:808-812. doi: 10.1038/nature07240.
56. Ivanov II, Atarashi K, Manel N etal. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-498. doi: 10.1016/j.cell.2009.09.033.
57. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010; 107:12204-12209. doi: 10.1073/pnas.0909122107.
58. De La Cochetiere MF, Durand T, Lepage P, Bourreille A, Galmiche JP, Dore J. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 2005; 43:5588-5592. doi: 10.1128/JCM.43.11.5588-5592.2005.
59. Zhang Y, Limaye PB, Renaud HJ, Klaassen CD. Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice. Toxicol Appl Pharmacol 2014; 277:138-145. doi: 10.1016/j.taap.2014.03.009.
60. Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004; 42:1203-1206.
61. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009; 77:2367-2375. doi: 10.1128/IAI.01520-08.
62. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLOS Biol 2008; 6:e280. doi: 10.1371/journal.pbio.0060280.
63. Bassis CM, Theriot CM, Young VB. Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection. Antimicrob Agents Chemother 2014; 58:2767-2774. doi: 10.1128/AAC.02262-13.
64. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010; 156:3216-3223. doi: 10.1099/mic.0.040618-0.
65. Lofmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 2010; 50 (Suppl. 1):S16-23. doi: 10.1086/647939.
66. Marzano IM, Franco MS, Silva PP etal. Crystal structure, antibacterial and cytotoxic activities of a new complex of bismuth(III) with sulfapyridine. Molecules 2013; 18:1464-1476. doi: 10.3390/molecules18021464.
67. Donskey CJ, Hujer AM, Das SM, Pultz NJ, Bonomo RA, Rice LB. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J Microbiol Methods 2003; 54:249-256.
68. Meyer-Hoffert U, Hornef MW, Henriques-Normark B etal. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 2008; 57:764-771. doi: 10.1136/gut.2007.141481.
69. Brandl K, Plitas G, Mihu CN etal. Vancomycin-resistant enterococci exploit antibiotic- induced innate immune deficits. Nature 2008; 455:804-807. doi: 10.1038/nature07250.
70. Dessein R, Gironella M, Vignal C etal. Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis. Gut 2009; 58:771-776. doi: 10.1136/gut.2008.168443.
71. Dufour V, Millon L, Faucher JF etal. Effects of a short-course of amoxicillin/clavulanic acid on systemic and mucosal immunity in healthy adult humans. Int Immunopharmacol 2005; 5:917-928. doi: 10.1016/j.intimp.2005.01.007.
72. Schumann A, Nutten S, Donnicola D etal. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics 2005; 23:235-245. doi: 10.1152/physiolgenomics.00057.2005.
73. Ivanov II, Frutos Rde L, Manel N etal. Specific microbiota direct the differentiation of IL-17- producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008; 4:337-349. doi: 10.1016/j.chom.2008.09.009.
74. Hill DA, Hoffmann C, Abt MC etal. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 2010; 3:148-158. doi: 10.1038/mi.2009.132.
75. Willing BP, Dicksved J, Halfvarson J etal. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139:1844-54.e1. doi: 10.1053/j.gastro.2010.08.049.
76. Boleij A, Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev Camb Phil Soc 2012; 87:701-730. doi: 10.1111/j.1469-185X.2012.00218.x.
77. Rutter M, Saunders B, Wilkinson K etal. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126:451-459.
78. Sokol H, Pigneur B, Watterlot L etal. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105:16731-16736. doi: 10.1073/pnas.0804812105.
79. Berry D, Reinisch W. Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases? Best Pract Res Clin Gastroenterol 2013; 27:47-58. doi: 10.1016/j.bpg.2013.03.005.
80. Wu S, Rhee KJ, Albesiano E etal. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15:1016-1022. doi: 10.1038/nm.2015.
81. Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 2003; 124:392-400. doi: 10.1053/gast.2003.50047.
82. Huycke MM, Abrams V, Moore DR. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 2002; 23:529-536.
83. Nougayrede JP, Homburg S, Taieb F etal. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006; 313:848-851. doi: 10.1126/science.1127059.
84. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA 2010; 107:11537-11542. doi: 10.1073/pnas.1001261107.
85. Schwabe RF, Wang TC. Cancer. Bacteria deliver a genotoxic hit. Science 2012; 338:52-53. doi: 10.1126/science.1229905.
86. Boleij A, Muytjens CM, Bukhari SI etal. Novel clues on the specific association of Streptococcus gallolyticus subsp. gallolyticus with colorectal cancer. J Infect Dis 2011; 203:1101-1109. doi: 10.1093/infdis/jiq169.
87. Boleij A, Schaeps RM, Tjalsma H. Association between Streptococcus bovis and colon cancer. J Clin Microbiol 2009; 47:516. doi: 10.1128/JCM.01755-08.
88. Kostic AD, Gevers D, Pedamallu CS etal. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22:292-298. doi: 10.1101/gr.126573.111.
89. Signat B, Roques C, Poulet P, Duffaut D. Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol 2011; 13:25-36.
90. Zheng L, Giri B. Gastrointestinal variant of Lemierre syndrome: Fusobacterium nucleatum bacteremia-associated hepatic vein thrombosis: a case report and literature review. Am J Ther 2014; doi: 10.1097/MJT.0000000000000084.
91. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-1023. doi: 10.1038/4441022a.
92. Keeney KM, Yurist-Doutsch S, Arrieta MC, Finlay BB. Effects of antibiotics on human microbiota and subsequent disease. Annu Rev Microbiol 2014; 68:217-235. doi: 10.1146/annurev-micro-091313-103456.
93. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3:213-223. doi: 10.1016/j.chom.2008.02.015.
94. Giongo A, Gano KA, Crabb DB etal. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011; 5:82-91. doi: 10.1038/ismej.2010.92.
95. Brugman S, Klatter FA, Visser JT etal. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006; 49:2105-2108. doi: 10.1007/s00125-006-0334-0.
96. Franceschi C, Bonafe M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000; 18:1717-1720.
97. Sansoni P, Cossarizza A, Brianti V etal. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 1993; 82:2767-2773.
98. Zanni F, Vescovini R, Biasini C etal. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 2003; 38:981-987.
99. Franceschi C, Bonafe M, Valensin S etal. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000; 908:244-254.
100. Gassler N, Rohr C, Schneider A etal. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001; 281:G216-228.
101. Zeissig S, Burgel N, Gunzel D etal. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007; 56:61-72. doi: 10.1136/gut.2006.094375.
102. Kaser A, Lee AH, Franke A etal. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008; 134:743-756. doi: 10.1016/j.cell.2008.07.021.
103. Heazlewood CK, Cook MC, Eri R etal. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLOS Med 2008; 5:e54. doi: 10.1371/journal.pmed.0050054.
104. Salzman NH, Hung K, Haribhai D etal. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11:76-83. doi: 10.1038/ni.1825.
105. Garrett WS, Lord GM, Punit S etal. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007; 131:33-45. doi: 10.1016/j.cell.2007.08.017.
106. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104:13780-13785. doi: 10.1073/pnas.0706625104.
107. Mondot S, Kang S, Furet JP etal. Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis 2011; 17:185-192. doi: 10.1002/ibd.21436.
108. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D, Garcia-Gil LJ. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis 2006; 12:1136-1145. doi: 10.1097/01.mib.0000235828.09305.0c.
109. Png CW, Linden SK, Gilshenan KS etal. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010; 105:2420-2428. doi: 10.1038/ajg.2010.281.
110. Andoh A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis 2007; 13:955-962. doi: 10.1002/ibd.20151.
111. Swidsinski A, Loening-Baucke V, Theissig F etal. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 2007; 56:343-350. doi: 10.1136/gut.2006.098160.
112. Darfeuille-Michaud A, Neut C, Barnich N etal. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115:1405-1413.
113. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 1999; 67:4499-4509.
114. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12:99-113. doi: 10.1111/j.1462-5822.2009.01381.x.
115. Brest P, Lapaquette P, Souidi M etal. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet 2011; 43:242-245. doi: 10.1038/ng.762.
116. Barnich N, Carvalho FA, Glasser AL etal. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007; 117:1566-1574. doi: 10.1172/JCI30504.
117. Arthur JC, Perez-Chanona E, Muhlbauer M etal. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012; 338:120-123. doi: 10.1126/science.1224820.
118. Hu B, Elinav E, Huber S etal. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci USA 2013; 110:9862-9867. doi: 10.1073/pnas.1307575110.
119. Arumugam M, Raes J, Pelletier E etal. Enterotypes of the human gut microbiome. Nature 2011; 473:174-180. doi: 10.1038/nature09944.
120. Wu GD, Chen J, Hoffmann C etal. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334:105-108. doi: 10.1126/science.1208344.
121. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA etal. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009; 137:1716-24.e1-2. doi: 10.1053/j.gastro.2009.08.042.
122. Zimmer J, Lange B, Frick JS etal. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 2012; 66:53-60. doi: 10.1038/ejcn.2011.141.
123. Kabeerdoss J, Devi RS, Mary RR, Ramakrishna BS. Faecal microbiota composition in vegetarians: comparison with omnivores in a cohort of young women in southern India. Br J Nutr 2012; 108:953-957. doi: 10.1017/S0007114511006362.
124. David LA, Maurice CF, Carmody RN etal. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 23:559-563. doi: 10.1038/nature12820.
125. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 2005; 16:77-84.
126. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81 (1 Suppl.):317S-325.
127. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002; 52:23-47.
128. Dunn JE. Cancer epidemiology in populations of the United States - with emphasis on Hawaii and California - and Japan. Cancer Res 1975; 35:3240-3245.
129. Gray GE, Pike MC, Henderson BE. Breast-cancer incidence and mortality rates in different countries in relation to known risk factors and dietary practices. Br J Cancer 1979; 39:1-7.
130. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21:113-131. doi: 10.1080/01635589409514310.
131. Price KR, Fenwick GR. Naturally occurring oestrogens in foods - a review. Food Addit Contam 1985; 2:73-106. doi: 10.1080/02652038509373531.
132. Bolca S, Possemiers S, Herregat A etal. Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J Nutr 2007; 137:2242-2246.
133. Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 1993; 45:399-405.
134. Muthyala RS, Ju YH, Sheng S etal. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004; 12:1559-1567. doi: 10.1016/j.bmc.2003.11.035.
135. Cruz ML, Wong WW, Mimouni F etal. Effects of infant nutrition on cholesterol synthesis rates. Pediatr Res 1994; 35:135-140. doi: 10.1203/00006450-199402000-00001.
136. Rowland I, Wiseman H, Sanders T, Adlercreutz H, Bowey E. Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Trans 1999; 27:304-308.
137. Atkinson C, Berman S, Humbert O, Lampe JW. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr 2004; 134:596-599.
138. Frankenfeld CL, McTiernan A, Tworoger SS etal. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post- menopausal women in relation to daidzein-metabolizing phenotypes. J Steroid Biochem Mol Biol 2004; 88:399-408. doi: 10.1016/j.jsbmb.2004.01.006.
139. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 2000; 36:27-32. doi: 10.1207/S15327914NC3601_5.
140. Frankenfeld CL, Atkinson C, Thomas WK etal. Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med 2004; 229:902-913.
141. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009; 15:285-289. doi: 10.1016/j.anaerobe.2009.09.007.
142. Shahinas D, Silverman M, Sittler T etal. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio 2012; 23: pii: e00338-12. doi: 10.1128/mBio.00338-12.
143. Osman N, Adawi D, Molin G, Ahrne S, Berggren A, Jeppsson B. Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol 2006; 6:31. doi: 10.1186/1471-230X-6-31.
144. Buddington KK, Donahoo JB, Buddington RK. Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers. J Nutr 2002; 132:472-477.
145. Deriu E, Liu JZ, Pezeshki M etal. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 2013; 14:26-37. doi: 10.1016/j.chom.2013.06.007.
146. McNulty NP, Yatsunenko T, Hsiao A etal. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 2011; 3:106ra. doi: 10.1126/scitranslmed.3002701.